Skip to main content
Corporate navigation
Company
Sustainability
Investors
Careers
Newsroom
International
US
If visiting the DiaSorin Site from a region that doesn't coincide with your location, some products may not be available. This is due to regulatory requirements and restrictions.
IT
EN
Mobile: Main menu
BACK
Immunodiagnostics
Immunodiagnostics
BACK
Overview
Infectious diseases
Gastrointestinal diseases
Hepatitis and retroviruses
Endocrinology
Metabolic disorders
Tumor Markers
Instruments
BACK
Instruments
LIAISON
®
XL
LIAISON
®
XS
Dialog
Molecular Diagnostics
Molecular Diagnostics
BACK
Overview
Technologies
BACK
Technologies
VERIGENE
®
NanoGrid Technology
Simplexa™ Real-Time PCR
xTAG
®
and NxTAG
®
Technology
Instruments
BACK
Instruments
LIAISON
®
MDX
The VERIGENE
®
System
MAGPIX
®
System
Kits and Reagents
BACK
Kits and Reagents
By Disease State
BACK
By Disease State
Bloodstream
CNS
Gastrointestinal
Genetics
Healthcare-Associated Infections
Respiratory
Women’s Health
By Format
BACK
By Format
Molecular Primer Pairs
Molecular Controls
Molecular Reagents
Dialog
Product Documentation
Luminex LTG
Luminex LTG
BACK
Overview
xMAP
®
Technology
BACK
xMAP
®
Technology
Applications
BACK
Applications
Bead-Based Multiplexing
xMAP
®
Assay Automation
Immunogenicity
xMAP
®
Microspheres
Instruments
BACK
Instruments
xMAP INTELLIFLEX
®
System
FLEXMAP 3D
®
System
Luminex
®
200™ System
MAGPIX
®
System
Reagents & Accessories
BACK
Reagents & Accessories
xMAP
®
Kit Finder
Microspheres
BACK
Microspheres
MagPlex-TAG™ Microspheres
MagPlex
®
Microspheres
MagPlex
®
-Avidin Microspheres
MagPlex
®
Monitoring Microspheres
MicroPlex
®
Microspheres
SeroMAP
TM
Microspheres
Coupling Accessories
BACK
Coupling Accessories
xMAP
®
Antibody Coupling Kit
Magnetic separators
xPONENT
®
Software
Product documentation
Service & Support
Service & Support
BACK
Overview
Immunodiagnostics
Molecular Diagnostics
Luminex LTG
BACK
Luminex LTG
Field Service Training Sessions
Maintenance Support Plans
Luminex Learning Sessions
LuminexPLORE Lab
My Luminex
Mobile: Corporate navigation
Company
Sustainability
Investors
Careers
Newsroom
Mobile: Company
BACK
Company
Who we are
BACK
Who we are
Our Story
Our sustainability strategy
Leadership
BACK
Leadership
Michele Denegri
Carlo Rosa
Chen Even
Angelo Rago
Piergiorgio Pedron
Stefano Ronchi
Business Model
Specialists in Innovation
Governance
BACK
Governance
Governance documents
BACK
Governance documents
By-Laws
Procedures
Code of Ethics and Model 231
Reports on Corporate Governance
Corporate bodies
Shareholders' meeting
Remuneration
BACK
Remuneration
Reports on remuneration
Information Documents Incentive Plans
Internal dealing operations
Buy back program
Ownership structure
BACK
Ownership structure
Total shareholders’ basis
Loyalty shares
Financial calendar
Transparency Obligations
Personal Data Protection
Diasorin worldwide
Mobile: Sustainability
BACK
Sustainability
Material issues
BACK
Material issues
Health and safety
Management of relations with local communities
Staff training and development
Employment and dialogue with social partners
Employees’ welfare
Diversity and inclusion
Environmental management
Business ethics, fight against corruption and anti-competitive behavior
Research, innovation and technological excellence
Customer satisfaction
Quality of products and processes
Human Rights
ESG
2023-2025 ESG Objectives
Resources
Mobile: Investors
BACK
Investors
Investor Day 2023
Financial corner
BACK
Financial corner
Results
Press releases
Presentations
Annual & Interim Reports
Bond
Coverage
Keep in touch
Calendar
Stock price
Stock market indices and trading codes
Information documents
Mobile: Careers
BACK
Careers
Merit Principles
BACK
Merit Principles
Our Culture
Diversity & Inclusion
People Strategy
Join us
Unisciti a noi
Mobile: Newsroom
BACK
Newsroom
Press Releases
Press Kit
Video gallery
Image gallery
International
US
If visiting the DiaSorin Site from a region that doesn't coincide with your location, some products may not be available. This is due to regulatory requirements and restrictions.
IT
EN
Main menu
BACK
Immunodiagnostics
Immunodiagnostics
BACK
Overview
Infectious diseases
Gastrointestinal diseases
Hepatitis and retroviruses
Endocrinology
Metabolic disorders
Tumor Markers
Instruments
BACK
Instruments
LIAISON
®
XL
LIAISON
®
XS
Dialog
Molecular Diagnostics
Molecular Diagnostics
BACK
Overview
Technologies
BACK
Technologies
VERIGENE
®
NanoGrid Technology
Simplexa™ Real-Time PCR
xTAG
®
and NxTAG
®
Technology
Instruments
BACK
Instruments
LIAISON
®
MDX
The VERIGENE
®
System
MAGPIX
®
System
Kits and Reagents
BACK
Kits and Reagents
By Disease State
BACK
By Disease State
Bloodstream
CNS
Gastrointestinal
Genetics
Healthcare-Associated Infections
Respiratory
Women’s Health
By Format
BACK
By Format
Molecular Primer Pairs
Molecular Controls
Molecular Reagents
Dialog
Product Documentation
Luminex LTG
Luminex LTG
BACK
Overview
xMAP
®
Technology
BACK
xMAP
®
Technology
Applications
BACK
Applications
Bead-Based Multiplexing
xMAP
®
Assay Automation
Immunogenicity
xMAP
®
Microspheres
Instruments
BACK
Instruments
xMAP INTELLIFLEX
®
System
FLEXMAP 3D
®
System
Luminex
®
200™ System
MAGPIX
®
System
Reagents & Accessories
BACK
Reagents & Accessories
xMAP
®
Kit Finder
Microspheres
BACK
Microspheres
MagPlex-TAG™ Microspheres
MagPlex
®
Microspheres
MagPlex
®
-Avidin Microspheres
MagPlex
®
Monitoring Microspheres
MicroPlex
®
Microspheres
SeroMAP
TM
Microspheres
Coupling Accessories
BACK
Coupling Accessories
xMAP
®
Antibody Coupling Kit
Magnetic separators
xPONENT
®
Software
Product documentation
Service & Support
Service & Support
BACK
Overview
Immunodiagnostics
Molecular Diagnostics
Luminex LTG
BACK
Luminex LTG
Field Service Training Sessions
Maintenance Support Plans
Luminex Learning Sessions
LuminexPLORE Lab
My Luminex
Home
Company
Governance
Buy back program
Buy back program
Select by year
2023
2022
(-)
2021
2020
2018
2016
05/11/2021
Report treasury shares buy-back
2.15 MB
Download
02/11/2021
Report treasury shares buy-back
3.5 MB
Download
02/11/2021
Conclusion treasury shares buy-back plan
294.67 KB
Download
30/07/2021
Start up of the treasury shares buy-back plan
773.96 KB
Download
12/04/2021
Weekly report treasury shares buy-back
914.42 KB
Download
06/04/2021
Start up of the treasury shares buy-back plan
774.02 KB
Download